Skip to Content
Merck
  • High-throughput and quantitative assessment of enhancer activity in mammals by CapStarr-seq.

High-throughput and quantitative assessment of enhancer activity in mammals by CapStarr-seq.

Nature communications (2015-04-16)
Laurent Vanhille, Aurélien Griffon, Muhammad Ahmad Maqbool, Joaquin Zacarias-Cabeza, Lan T M Dao, Nicolas Fernandez, Benoit Ballester, Jean Christophe Andrau, Salvatore Spicuglia
ABSTRACT

Cell-type specific regulation of gene expression requires the activation of promoters by distal genomic elements defined as enhancers. The identification and the characterization of enhancers are challenging in mammals due to their genome complexity. Here we develop CapStarr-Seq, a novel high-throughput strategy to quantitatively assess enhancer activity in mammals. This approach couples capture of regions of interest to previously developed Starr-seq technique. Extensive assessment of CapStarr-seq demonstrates accurate quantification of enhancer activity. Furthermore, we find that enhancer strength is associated with binding complexity of tissue-specific transcription factors and super-enhancers, while additive enhancer activity isolates key genes involved in cell identity and function. The CapStarr-Seq thus provides a fast and cost-effective approach to assess the activity of potential enhancers for a given cell type and will be helpful in decrypting transcription regulation mechanisms.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Ethylenediaminetetraacetic acid, purified grade, ≥98.5%, powder
Sigma-Aldrich
Ethylenediaminetetraacetic acid, anhydrous, BioUltra, ≥99% (titration)
Sigma-Aldrich
Ethylenediaminetetraacetic acid, ACS reagent, 99.4-100.6%, powder
Sigma-Aldrich
Phenylacetic acid, ≥99%, FCC, FG
Sigma-Aldrich
Neon-20Ne, 99.95 atom %, 99.995% (CP)
Sigma-Aldrich
Neon-20Ne, 70 atom %
Sigma-Aldrich
Neon-20Ne, 99.95 atom %
Sigma-Aldrich
Neon-20Ne, 99.9 atom %